source
- Summit's PD-1xVEGF rejected by FDA in lung cancerThe FDA has denied an approval for Summit Therapeutics’ ivonescimab to treat EGFR-mutated non-small cell lung cancer, blocking the drug’s entry to the U.S. after it became available in China in 2024.BioSpace · 1h ago↗ source
- Medline recalls all brand beds, rails, mattresses and accessories over fire and entrapment riskMedline announced a recall of its entire line of Medline Brand beds, rails, mattresses and related accessories in the United States and Canada. The recall, launched on October 14, 2026, cites a po…